openPR Logo
Press release

PEGylated Protein Therapeutics Market Outlook 2025: Key Players Amgen, AstraZeneca, Biogen, Horizon Pharma

02-11-2019 11:18 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
PEGylated Protein Therapeutics Market Outlook 2025: Key

PEGylation is the process of adding active polyethylene glycol (PEG) to various forms of therapeutic proteins for chemical modification. These chemically modified therapeutic proteins are called pegylated protein therapeutics. Chemical modification due to PEGylation brings about various advantages such as extended half-life of the drug with lower toxicity and increased proteolytic protection than unmodified protein therapy. PEGylated protein therapeutics are used in many conditions such as cancer, hemophilia, rheumatoid arthritis, ankylosing spondylitis, Crohns disease and others.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/3726?utm_source=openpr_ss

According to Allied Market Research, the market was valued at $10,388 million in 2017 and is projected to reach $17,813 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

Factors driving the growth of the global PEGylated protein therapeutics market are the prevalence of chronic diseases, the benefits of PEGylation and the strong presence of pipeline drugs. However, high costs associated with drug development and generic launches are expected to hamper market growth. In addition, the high market potential in untapped emerging economies and the increased adoption of PEGylated protein therapeutics are expected to provide many opportunities during the forecast period.

By product type, colonial stimuli accounted for nearly half of the worldwide industrial medicines market share in 2017. Also, the cancer portion is expected to grow at a high rate of 7.4% over the forecast period.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3726?utm_source=openpr_ss

Major Market Players:

• Amgen Inc.
• AstraZeneca PLC
• Biogen Inc.
• F. Hoffmann-La Roche Ltd. (Genentech Inc.)
• Horizon Pharma plc.

key Findings of the Study:

• North America occupied an almost two-thirds share of the global PEGylated protein therapeutics market in 2017

• Cancer cells are expected to grow at the highest CAGR throughout the forecast period.

• Europe is expected to account for one-fifth of the worldwide market for PEGylated protein therapeutics by 2025.

• The Asia Pacific region is expected to grow at the highest rate during the analysis period, followed by LAMEA.

Browse More Information of Report @ https://www.alliedmarketresearch.com/press-release/PEGylated-proteins-market.html

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PEGylated Protein Therapeutics Market Outlook 2025: Key Players Amgen, AstraZeneca, Biogen, Horizon Pharma here

News-ID: 1576249 • Views:

More Releases from Allied Market Research

Revolutionizing Healthcare: Protein Engineering Market Soars with a CAGR of 13.2%
Revolutionizing Healthcare: Protein Engineering Market Soars with a CAGR of 13.2 …
The global protein engineering market witnessed a remarkable rise, surging from $2.2 billion in 2022 to a projected $7.7 billion by 2032, with a robust Compound Annual Growth Rate (CAGR) of 13.2% between 2023 and 2032. This surge is attributed to the expanding applications across biopharmaceuticals, industrial sectors, and research domains. Notably, the escalation in cancer cases plays a pivotal role in propelling market growth, as protein engineering spearheads the
Tomato Puree Market Value Projected to Expand | $7.7 Billion by 2032 With CAGR of 4.1%
Tomato Puree Market Value Projected to Expand | $7.7 Billion by 2032 With CAGR o …
The tomato puree market was valued at $5.2 billion in 2022, and is estimated to reach $7.7 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032. Tomato puree is a thick liquid or paste made by cooking and straining tomatoes to remove seeds and skins. It is a concentrated form of tomatoes that retains the rich flavor and vibrant color of the tomatoes. In the process
Olive Oil Market to Witness Robust Expansion | $30.2 Billion by 2032
Olive Oil Market to Witness Robust Expansion | $30.2 Billion by 2032
The olive oil market size was valued at $18.6 billion in 2022, and is estimated to reach $30.2 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032. The Olive Oil Industry is driven by a rise in the number of cooking shows and food blogging. Celebrity chefs and influencers often showcase olive oil as a star ingredient in various culinary creations, emphasizing its versatility and health benefits.
Digital Map Market Growth, Size, Future Scope and Industry Forecast 2032
Digital Map Market Growth, Size, Future Scope and Industry Forecast 2032
The digital map industry was valued at $21.8 billion in 2022, and is estimated to reach $89.1 billion by 2032, growing at a CAGR of 15.4% from 2023 to 2032. The service segment is expected to experience fastest growth in the coming years. The adoption of digital mapping service enhances software implementation, maximizes the value of existing installation by optimizing it, and minimizes the deployment cost & risks, and others, which

All 5 Releases


More Releases for PEG

Biopharma PEG Provides Monodisperse PEGs In Drug Development
Monodisperse PEG products usually are organic compounds with a molecular weight of less than 1000. Monodispersed PEG linkers are pure compounds with a single molecular weight. Monodisperse polyethylene glycol(PEG) molecular weight is fixed. It can not be obtained by polymerization. It must be by the appropriate reaction of the basic polyethylene glycol fragment. With advancements in both synthetic and purification chemistry over the past two decades, monodispersed PEG linkers have become more commercially
High Quality PEG Raw Materials From Biopharma PEG
Polyethylene glycol (PEG) is a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine. PEG is also known as polyethylene oxide (PEO) or polyoxyethylene (POE), it has wide variety of applications depending on the length of the polymer chain and the molecular weight of the final polymer. The synthesis of PEG is done by polymerizing ethylene oxide, the main ingredient in antifreeze, using a ring-opening
Polyethylene Glycol (PEG) in Medical Market 2021 | Detailed Report
ReportsnReports publishes the report titled Polyethylene Glycol (PEG) in Medical that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital
PEG-3 Distearate Market global outlook and forecast 2021 -2027
The Global PEG-3 Distearate Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a PEG-3 Distearate makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The report likewise spins around
The Advantages of Monodisperse PEG In Drug Development?
Monodisperse PEG products usually are organic compounds with a molecular weight of less than 1000. Monodispersed PEG linkers are pure compounds with a single molecular weight. In contrast, polydisperse PEGs linkers contain variations in molecular weight with an average molecular weight. The use of polydisperse PEGs linkers in drug development has led to problems in biological applications due to steric hindrance and binding. With advancements in both synthetic and purification chemistry over the
Application of PEG In Click Chemistry
Polyethylene glycol (PEG) is a biocompatible, synthetic, hydrophilic polyether compound that has many applications, mostly in the medical industry, but also in the chemical and industrial sectors. The synthesis of PEG is done by polymerizing ethylene oxide, the main ingredient in antifreeze, using a ring-opening technique, which allows for PEGs of a range of molecular weights and molecular weight distributions to be constructed. This range in weights is what makes